Literature DB >> 12404886

Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections.

Vera Della Casa1, Harald Noll, Susanne Gonser, Philipp Grob, Federico Graf, Gabriele Pohlig.   

Abstract

Dequalinium chloride (CAS 522-51-0) and povidone iodine (CAS 25655-41-8) are known as antiseptic agents and used in the local treatment of vaginal infections. Clotrimazole (CAS 23593-75-1) is an anti-fungal drug and applied primarily in the therapy of vulvo-vaginal candidiasis and to a lesser extent in bacterial vaginosis and trichomoniasis. However, antimicrobial activities of those three agents in comparison to each other have not been reported so far. To address this issue the antimicrobial activities of these agents against 18 germs relevant to vaginal infections were determined. The tested species are representatives of the genera Staphylococcus, Streptococcus, Enterococcus, Listeria, Escherichia, Proteus, Gardnerella, Bacteroides, Prevotella, Porphyromonas, Candida, and Trichomonas. All micro-organisms were susceptible to dequalinium chloride with the exception of Proteus mirabilis. At a given dose, the activity of dequalinium chloride was higher as compared to the other substances. In view of its wide antimicrobial spectrum dequalinium chloride is an efficient alternative in the local therapy of vaginal infections such as fluor vaginalis, bacterial vaginosis, aerobic vaginitis, vulvo-vaginal candidiasis and trichomoniasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404886     DOI: 10.1055/s-0031-1299954

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  11 in total

1.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

2.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

Review 3.  Caenorhabditis elegans-based model systems for antifungal drug discovery.

Authors:  Cleo G Anastassopoulou; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Effect of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes.

Authors:  Juan R Rodrigues; Neira D Gamboa
Journal:  Parasitol Res       Date:  2009-02-11       Impact factor: 2.289

5.  Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening.

Authors:  Maria-Teresa Gutierrez-Lugo; Heather Baker; Joseph Shiloach; Helena Boshoff; Carole A Bewley
Journal:  J Biomol Screen       Date:  2009-06-12

6.  Susceptibility testing of Atopobium vaginae for dequalinium chloride.

Authors:  Guido Lopes dos Santos Santiago; Philipp Grob; Hans Verstraelen; Florian Waser; Mario Vaneechoutte
Journal:  BMC Res Notes       Date:  2012-03-19

7.  XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells.

Authors:  Daniel Moreno-Martínez; Meritxell Nomdedeu; María Carmen Lara-Castillo; Amaia Etxabe; Marta Pratcorona; Niccolò Tesi; Marina Díaz-Beyá; María Rozman; Emili Montserrat; Alvaro Urbano-Ispizua; Jordi Esteve; Ruth M Risueño
Journal:  Oncotarget       Date:  2014-06-30

8.  Identification of a novel potassium channel (GiK) as a potential drug target in Giardia lamblia: Computational descriptions of binding sites.

Authors:  Lissethe Palomo-Ligas; Filiberto Gutiérrez-Gutiérrez; Verónica Yadira Ochoa-Maganda; Rafael Cortés-Zárate; Claudia Lisette Charles-Niño; Araceli Castillo-Romero
Journal:  PeerJ       Date:  2019-02-27       Impact factor: 2.984

9.  Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Authors:  Ikechukwu Okoli; Jeffrey J Coleman; Emmanouil Tampakakis; Emmanouil Tempakakis; W Frank An; Edward Holson; Florence Wagner; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Andy Stern; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

Review 10.  Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review.

Authors:  Werner Mendling; Ernst Rainer Weissenbacher; Stefan Gerber; Valdas Prasauskas; Philipp Grob
Journal:  Arch Gynecol Obstet       Date:  2015-10-27       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.